Post-IPO Equity - Bluebird Bio - Jan 18, 2023 Funding Round Profile - Cointime

Bitcoin $94,170.81 -1.90%
Ethereum $3,328.53 -4.51%
BNB $619.02 -4.25%
Optimism $2.20 -4.66%
Arbitrum $0.87 -5.14%
Solana $231.58 -4.50%
Polygon $0.53 -7.52%
Cosmos $8.00 -2.14%
Avalanche $42.03 -1.74%

Bitcoin $94,170.81 -1.90%
Ethereum $3,328.53 -4.51%
BNB $619.02 -4.25%
Optimism $2.20 -4.66%
Arbitrum $0.87 -5.14%
Solana $231.58 -4.50%
Polygon $0.53 -7.52%
Cosmos $8.00 -2.14%
Avalanche $42.03 -1.74%

Bluebird Bio

company

Funding Round

Post-IPO Equity

Money Raised

$ 113.55M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion

Historical Financing

Announced Date	Round	Money Raised	Investors
Jul 25, 2012	Series D	$ 60M	ARCH Venture Partners,ArmaVir Partners,etc.	Detail
Apr 20, 2011	Series C	$ 30M	ARCH Venture Partners,Easton Capital,etc.	Detail
Jun 17, 2004	Series A	$ 8.50M	ABN AMRO Fund,Nazem and Company	Detail
Oct 27, 2012	Series Unknown	$ 9.30M	California Institute for Regenerative Medicine	Detail
Mar 12, 2010	Series B	$ 35M	Easton Capital,Forbion Capital Partners,etc.	Detail
Dec 7, 2016	Post-IPO Equity	$ 250M		Detail
Oct 7, 2004	Series Unknown	$ 12M	ABN AMRO Fund,Easton Capital,etc.	Detail
Mar 16, 2011	Grant	$ 4.20M		Detail
Sep 8, 2021	Post-IPO Equity	$ 75M		Detail
Jun 14, 2019	IPO	0		Detail